HomeInsightsPE

Panacea Biotec Ltd PE Ratio

Panacea Biotec Ltd PE Ratio

stocks purchased

₹ 1.2 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

28.9 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Panacea Biotec Ltd

NSE: PANACEABIO

PE

-

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Panacea Biotec Ltd is 0 as of 23 Nov 14:35 PM .
  • The P/E Ratio of Panacea Biotec Ltd changed from 32.2 on March 2019 to 0 on March 2024 . This represents a CAGR of -100.00% over 6 years.
  • The Latest Trading Price of Panacea Biotec Ltd is ₹ 409.45 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Panacea Biotec Ltd

No data available

Company Fundamentals for Panacea Biotec Ltd

No data available

Image

Panacea Biotec Ltd

NSE: PANACEABIO

Share Price

₹ 409.45

-5.30 (-1.28%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Panacea Biotec Ltd

1M

1Y

3Y

5Y

Monitoring Panacea Biotec Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024409.45
21 Nov 2024414.75
19 Nov 2024395.6
18 Nov 2024376.8
14 Nov 2024358.9
13 Nov 2024341.85
12 Nov 2024340.5
11 Nov 2024349.5
08 Nov 2024360.8
07 Nov 2024367.95

SWOT Analysis Of Panacea Biotec Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Panacea Biotec Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Panacea Biotec Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Panacea Biotec Ltd02,507
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Panacea Biotec Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Panacea Biotec Ltd

No data available

* All values are in crore

Historical Revenue of Panacea Biotec Ltd

No data available

* All values are in crore

Historical EBITDA of Panacea Biotec Ltd

No data available

* All values are in crore

Historical Net Profit of Panacea Biotec Ltd

No data available

* All values are in crore

Historical Dividend Payout of Panacea Biotec Ltd

No data available

* All values are in %

About Panacea Biotec Ltd

  • India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on 2nd February 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines.
  • The Company has collaborations and tie-ups with leading national and international research organizations and corporations.
  • PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers.

Panacea Biotec Ltd News Hub

News

Panacea Biotec reports consolidated net loss of Rs 15.88 crore in the June 2024 quarter

Net loss of Panacea Biotec reported to Rs 15.88 crore in the quarter ended June 2024 as ag...

Read more

2024-08-14 00:00:00

News

Panacea Biotec reports standalone net loss of Rs 13.78 crore in the June 2024 quarter

Net loss of Panacea Biotec reported to Rs 13.78 crore in the quarter ended June 2024 as ag...

Read more

2024-08-14 00:00:00

News

Panacea Biotec announces board meeting date

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 14 August 2...

Read more

2024-08-07 00:00:00

News

Panacea Biotec to hold AGM

Panacea Biotec announced that the Annual General Meeting (AGM) of the company will be held...

Read more

2024-09-18 00:00:00

News

Panacea Biotec to hold board meeting

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 13 November...

Read more

2024-10-31 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Panacea Biotec Ltd

What is the current PE Ratio of Panacea Biotec Ltd?

The Current PE Ratio of Panacea Biotec Ltd is 0.0 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of Panacea Biotec Ltd last year?

The PE Ratio of Panacea Biotec Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Panacea Biotec Ltd indicate about its stock?

The PE Ratio of Panacea Biotec Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Panacea Biotec Ltd.

What is the PE Ratio Growth of Panacea Biotec Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Panacea Biotec Ltd grew by -% whereas, the EPS ratio grew by -129.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*